Elezanumab (Anti-RGMA)
Elezanumab (Anti-RGMA) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway with IC50 of 97 pM. MW: 146.44 kD.
| Trivial name | ABT-555, AE12-1Y-QL |
| Catalog Number | A2370 |
| CAS# | 1791416-49-3 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/elezanumab-anti-rgma.html |